Mebendazole is a well-known antiparasitic medication used to treat intestinal worm infections. However, in recent years, it has gained attention for its off-label use as a potential cancer treatment. Though not officially approved for cancer therapy, early studies and anecdotal reports suggest that mebendazole may help inhibit the growth of certain cancer cells by disrupting microtubule formation, which is essential for cell division.
For those considering mebendazole for cancer, it is crucial to consult with a medical professional before starting, as research is still ongoing and dosage may vary depending on the individual case.
Typically, the off-label cancer protocol involves taking 100 mg of Mebendazole for Cancer once or twice daily, with food to enhance absorption. Some individuals alternate between five days on and two days off per week. Others use it continuously, depending on how their body responds. Because Mebendazole is poorly absorbed, taking it with a fatty meal (like avocado or coconut oil) may improve bioavailability.
This regimen is often combined with other supplements or medications under medical guidance, including vitamins, anti-inflammatory agents, or existing chemotherapy drugs, as part of a broader integrative cancer treatment approach.
It’s important to monitor liver function and blood counts regularly, especially with long-term use, to avoid toxicity or unwanted side effects.
While mebendazole shows promise in preclinical studies for cancers like glioblastoma, colon, lung, and melanoma, more human trials are needed to confirm its efficacy and safety.
.
